SoftOx Solutions AS Share Price Oslo Bors
Equities
NO0010811961
Biotechnology & Medical Research
Sales 2021 | 7.9M 718K 57.34M | Sales 2022 | 7.11M 647K 51.63M | Capitalization | 241M 21.91M 1.75B |
---|---|---|---|---|---|
Net income 2021 | -65M -5.91M -472M | Net income 2022 | -71M -6.45M -515M | EV / Sales 2021 | 64.3 x |
Net cash position 2021 | 56.98M 5.18M 414M | Net cash position 2022 | 6.91M 628K 50.12M | EV / Sales 2022 | 32.9 x |
P/E ratio 2021 |
-8.86
x | P/E ratio 2022 |
-3.39
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.54% |
Latest transcript on SoftOx Solutions AS
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 20/06/12 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 16/04/15 |
Geir Almås
FOU | Founder | - | 20/06/12 |
Adrian Bignami
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |